Results 171 to 180 of about 7,833 (210)

Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia. [PDF]

Oncologist
Lenihan D, Bloom M, Copeland-Halperin R, Fleming MR, Fradley M, O'Quinn R, Bhat SA.   +6 more
europepmc   +1 more source

Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers. [PDF]

Front Oncol
Kluitmans DJF, Melis JJTM, van den Bossche E, Ytsma J, de Roos JADM, van Linden OPJ, Grobben Y, Kooijman JJ, Zaman GJR.   +8 more
europepmc   +1 more source

Discovery of Reversible, Noncovalent Bruton's Tyrosine Kinase Inhibitors Targeting BTK C481S Mutation. [PDF]

ACS Med Chem Lett
Das D, Xie L, Qiao D, Cao Y, Jiang S, Zheng M, Liu Z, Li Y, Jia J, Lv Y, Hong J.   +10 more
europepmc   +1 more source

In Silico Molecular Docking Analysis of Valproic Acid as an Inhibitor of Bruton's Tyrosine Kinase: Potential Drug Repurposing for Allergies. [PDF]

Cureus
Martinez-Martinez RE, Calva-Hernandez CI, Rodriguez-Lopez GM, Soria-Castro R, Ruiz-Sanchez BP, Chavez-Blanco AD, Pérez-Tapia SM, Pavano-Rodriguez CG, Chacon-Salinas R.   +8 more
europepmc   +1 more source

Inhibition of bruton's tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis. [PDF]

J Neuroinflammation
Xiao Z, Li Z, Zhu W, Chen G, Luo X, Mai Z, Wang M, Huang H, Li Z, Shi Y, Xie Y, Wu H, Chen X, Liang D.   +13 more
europepmc   +1 more source

Retraction: Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice. [PDF]

Front Immunol
Frontiers Editorial Office.
europepmc   +1 more source

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor. [PDF]

JAAD Case Rep
Kucharik AH, Curkovic NB, Chavez JC, Tsai KY, Brohl AS, Grichnik JM.   +5 more
europepmc   +1 more source

Bruton's Tyrosine Kinase Inhibitors: Recent Updates. [PDF]

Int J Mol Sci
Fares A, Carracedo Uribe C, Martinez D, Rehman T, Silva Rondon C, Sandoval-Sus J.   +5 more
europepmc   +1 more source

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. [PDF]

J Exp Clin Cancer Res
Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, Guo X, Zhao P.   +7 more
europepmc   +1 more source

The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas. [PDF]

Int J Mol Sci
Mehra S, Nicholls M, Taylor J.
europepmc   +1 more source